Tuberculosis, caused by the bacteria Mycobacterium tuberculosis, is a leading cause of death worldwide. In 2017 alone, 10 million people across the globe were affected by the disease, and about 1.6 million succumbed to it.

This study, by researchers from Hungary, India, France and the USA, explored the potential of some new chemical compounds as therapeutic agents against tuberculosis. Such compounds represent new possibilities for further anti-TB drug development.

Scientists from the Indian Institute of Science, Bangalore, study what effect tuberculosis has on the immune system of our body.

A new study conducted by Pallavi Sinha and group from Institute of Medical Sciences, Banaras Hindu University and Boston Medical Centre has concluded that behavioral factors, like alcohol consumption and smoking, and clinical factors, like previous anti tubercular treatment, increases the risk of multi-drug resistant TB (MDR-TB).